236 related articles for article (PubMed ID: 11056105)
1. Nitric oxide inhibits dystrophin proteolysis by coxsackieviral protease 2A through S-nitrosylation: A protective mechanism against enteroviral cardiomyopathy.
Badorff C; Fichtlscherer B; Rhoads RE; Zeiher AM; Muelsch A; Dimmeler S; Knowlton KU
Circulation; 2000 Oct; 102(18):2276-81. PubMed ID: 11056105
[TBL] [Abstract][Full Text] [Related]
2. Enteroviral protease 2A directly cleaves dystrophin and is inhibited by a dystrophin-based substrate analogue.
Badorff C; Berkely N; Mehrotra S; Talhouk JW; Rhoads RE; Knowlton KU
J Biol Chem; 2000 Apr; 275(15):11191-7. PubMed ID: 10753926
[TBL] [Abstract][Full Text] [Related]
3. Dystrophin disruption in enterovirus-induced myocarditis and dilated cardiomyopathy: from bench to bedside.
Badorff C; Knowlton KU
Med Microbiol Immunol; 2004 May; 193(2-3):121-6. PubMed ID: 12920582
[TBL] [Abstract][Full Text] [Related]
4. Nitric oxide donors inhibit the coxsackievirus B3 proteinases 2A and 3C in vitro, virus production in cells, and signs of myocarditis in virus-infected mice.
Zell R; Markgraf R; Schmidtke M; Görlach M; Stelzner A; Henke A; Sigusch HH; Glück B
Med Microbiol Immunol; 2004 May; 193(2-3):91-100. PubMed ID: 14513374
[TBL] [Abstract][Full Text] [Related]
5. Enteroviral protease 2A cleaves dystrophin: evidence of cytoskeletal disruption in an acquired cardiomyopathy.
Badorff C; Lee GH; Lamphear BJ; Martone ME; Campbell KP; Rhoads RE; Knowlton KU
Nat Med; 1999 Mar; 5(3):320-6. PubMed ID: 10086389
[TBL] [Abstract][Full Text] [Related]
6. Cleavage of osmosensitive transcriptional factor NFAT5 by Coxsackieviral protease 2A promotes viral replication.
Qiu Y; Ye X; Zhang HM; Hanson P; Zhao G; Tong L; Xie R; Yang D
PLoS Pathog; 2017 Dec; 13(12):e1006744. PubMed ID: 29220410
[TBL] [Abstract][Full Text] [Related]
7. Selective delivery of nitric oxide to a cellular target: a pseudosubstrate-coupled dinitrosyl-iron complex inhibits the enteroviral protease 2A.
Badorff C; Fichtlscherer B; Muelsch A; Zeiher AM; Dimmeler S
Nitric Oxide; 2002 May; 6(3):305-12. PubMed ID: 12009848
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of Coxsackievirus-associated dystrophin cleavage prevents cardiomyopathy.
Lim BK; Peter AK; Xiong D; Narezkina A; Yung A; Dalton ND; Hwang KK; Yajima T; Chen J; Knowlton KU
J Clin Invest; 2013 Dec; 123(12):5146-51. PubMed ID: 24200690
[TBL] [Abstract][Full Text] [Related]
9. Inducible cardiac-restricted expression of enteroviral protease 2A is sufficient to induce dilated cardiomyopathy.
Xiong D; Yajima T; Lim BK; Stenbit A; Dublin A; Dalton ND; Summers-Torres D; Molkentin JD; Duplain H; Wessely R; Chen J; Knowlton KU
Circulation; 2007 Jan; 115(1):94-102. PubMed ID: 17190866
[TBL] [Abstract][Full Text] [Related]
10. Enteroviral cardiomyopathy: bad news for the dystrophin-glycoprotein complex.
Badorff C; Lee GH; Knowlton KU
Herz; 2000 May; 25(3):227-32. PubMed ID: 10904843
[TBL] [Abstract][Full Text] [Related]
11. Dissociation of sarcoglycans and the dystrophin carboxyl terminus from the sarcolemma in enteroviral cardiomyopathy.
Lee GH; Badorff C; Knowlton KU
Circ Res; 2000 Sep; 87(6):489-95. PubMed ID: 10988241
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of the catalytic activity of alcohol dehydrogenase by nitric oxide is associated with S nitrosylation and the release of zinc.
Gergel D; Cederbaum AI
Biochemistry; 1996 Dec; 35(50):16186-94. PubMed ID: 8973191
[TBL] [Abstract][Full Text] [Related]
13. Critical role of sulfenic acid formation of thiols in the inactivation of glyceraldehyde-3-phosphate dehydrogenase by nitric oxide.
Ishii T; Sunami O; Nakajima H; Nishio H; Takeuchi T; Hata F
Biochem Pharmacol; 1999 Jul; 58(1):133-43. PubMed ID: 10403526
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of cathepsin K by nitric oxide donors: evidence for the formation of mixed disulfides and a sulfenic acid.
Percival MD; Ouellet M; Campagnolo C; Claveau D; Li C
Biochemistry; 1999 Oct; 38(41):13574-83. PubMed ID: 10521264
[TBL] [Abstract][Full Text] [Related]
15. Nitric oxide and viral cardiomyopathy.
Finkel MS
Circulation; 2000 Oct; 102(18):2162-4. PubMed ID: 11056085
[No Abstract] [Full Text] [Related]
16. Coxsackievirus Protease 2A Targets Host Protease ATG4A to Impair Autophagy.
Fan YM; Zhang YL; Bahreyni A; Luo H; Mohamud Y
Viruses; 2022 Sep; 14(9):. PubMed ID: 36146840
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of apoptosis signal-regulating kinase 1 by nitric oxide through a thiol redox mechanism.
Park HS; Yu JW; Cho JH; Kim MS; Huh SH; Ryoo K; Choi EJ
J Biol Chem; 2004 Feb; 279(9):7584-90. PubMed ID: 14668338
[TBL] [Abstract][Full Text] [Related]
18. Cleavage and Sub-Cellular Redistribution of Nuclear Pore Protein 98 by Coxsackievirus B3 Protease 2A Impairs Cardioprotection.
Hanson PJ; Hossain AR; Qiu Y; Zhang HM; Zhao G; Li C; Lin V; Sulaimon S; Vlok M; Fung G; Chen VH; Jan E; McManus BM; Granville DJ; Yang D
Front Cell Infect Microbiol; 2019; 9():265. PubMed ID: 31396490
[TBL] [Abstract][Full Text] [Related]
19. An antiviral mechanism of nitric oxide: inhibition of a viral protease.
Saura M; Zaragoza C; McMillan A; Quick RA; Hohenadl C; Lowenstein JM; Lowenstein CJ
Immunity; 1999 Jan; 10(1):21-8. PubMed ID: 10023767
[TBL] [Abstract][Full Text] [Related]
20. Nitric oxide donors activate the cyclo-oxygenase and peroxidase activities of prostaglandin H synthase.
Maccarrone M; Putti S; Finazzi Agrò A
FEBS Lett; 1997 Jun; 410(2-3):470-6. PubMed ID: 9237685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
